Strides Pharma Science Limited (NSE:STAR)
India
· Delayed Price · Currency is INR 866.35
+1.50 (0.17%)
At close: Mar 9, 2026
Strides Pharma Science Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 79,854 | 61,675 | 72,114 | 25,858 | 31,121 | 75,754 | Upgrade
|
| Market Cap Growth | 34.29% | -14.47% | 178.88% | -16.91% | -58.92% | 162.55% | Upgrade
|
| Enterprise Value | 96,487 | 81,726 | 96,197 | 55,452 | 54,820 | 95,516 | Upgrade
|
| Last Close Price | 866.35 | 666.19 | 307.18 | 111.72 | 135.22 | 328.50 | Upgrade
|
| PE Ratio | 15.61 | 1.72 | - | - | - | 28.22 | Upgrade
|
| Forward PE | 12.71 | 13.18 | 26.97 | 22.79 | - | 22.19 | Upgrade
|
| PS Ratio | 1.69 | 1.35 | 1.85 | 0.70 | 1.01 | 2.29 | Upgrade
|
| PB Ratio | 2.85 | 2.38 | 3.48 | 1.19 | 1.31 | 2.69 | Upgrade
|
| P/TBV Ratio | 5.29 | 4.29 | 6.75 | 2.28 | 2.49 | 4.52 | Upgrade
|
| P/FCF Ratio | - | 13.96 | 12.37 | - | - | 41.18 | Upgrade
|
| P/OCF Ratio | - | 9.01 | 10.29 | 58.23 | - | 15.74 | Upgrade
|
| PEG Ratio | - | 4.38 | 4.38 | 4.38 | - | 0.10 | Upgrade
|
| EV/Sales Ratio | 2.04 | 1.79 | 2.47 | 1.50 | 1.79 | 2.88 | Upgrade
|
| EV/EBITDA Ratio | 10.97 | 10.63 | 17.91 | 16.30 | - | 16.07 | Upgrade
|
| EV/EBIT Ratio | 13.66 | 13.41 | 26.66 | 38.52 | - | 22.31 | Upgrade
|
| EV/FCF Ratio | - | 18.50 | 16.50 | - | - | 51.92 | Upgrade
|
| Debt / Equity Ratio | 0.66 | 0.73 | 1.22 | 1.39 | 1.27 | 0.83 | Upgrade
|
| Debt / EBITDA Ratio | 2.10 | 2.37 | 4.39 | 8.10 | - | 3.81 | Upgrade
|
| Debt / FCF Ratio | - | 4.25 | 4.32 | - | - | 12.77 | Upgrade
|
| Net Debt / Equity Ratio | 0.58 | 0.65 | 1.08 | 1.23 | 1.19 | 0.74 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.90 | 2.19 | 4.15 | 7.84 | -57.45 | 3.49 | Upgrade
|
| Net Debt / FCF Ratio | - | 3.80 | 3.82 | -52.82 | -7.08 | 11.27 | Upgrade
|
| Asset Turnover | - | 0.77 | 0.62 | 0.54 | 0.44 | 0.50 | Upgrade
|
| Inventory Turnover | - | 1.77 | 1.68 | 1.52 | 1.36 | 1.43 | Upgrade
|
| Quick Ratio | - | 0.62 | 0.55 | 0.59 | 0.58 | 0.52 | Upgrade
|
| Current Ratio | - | 1.20 | 1.03 | 1.09 | 0.99 | 1.03 | Upgrade
|
| Return on Equity (ROE) | - | 17.58% | -6.78% | -10.13% | -18.25% | 9.01% | Upgrade
|
| Return on Assets (ROA) | - | 6.41% | 3.62% | 1.32% | -2.12% | 4.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.49% | 11.96% | 7.90% | 2.86% | -4.69% | 8.09% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 17.60% | 12.20% | 3.90% | -6.70% | 10.00% | Upgrade
|
| Earnings Yield | 6.40% | 58.26% | -0.98% | -7.84% | -14.79% | 3.54% | Upgrade
|
| FCF Yield | - | 7.17% | 8.08% | -1.95% | -12.89% | 2.43% | Upgrade
|
| Dividend Yield | 0.46% | 0.60% | 0.81% | 1.34% | - | 0.76% | Upgrade
|
| Payout Ratio | 7.21% | 0.64% | - | - | - | 6.67% | Upgrade
|
| Buyback Yield / Dilution | -0.23% | -1.12% | -1.02% | -0.37% | -0.04% | -0.14% | Upgrade
|
| Total Shareholder Return | 0.24% | -0.52% | -0.21% | 0.97% | -0.04% | 0.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.